Exercise snacking using aerobic, resistance, or balance exercise at moderate-to-vigorous intensity; sessions lasted ≤10 minutes and were performed two to six times daily.
Exercise Snacks
Exercise Snacking for Chronic Conditions: Scoping Review
This evidence map and scoping review covers 23 studies of brief aerobic, resistance, or balance exercise bouts in 560 people with chronic conditions or cardiometabolic risk, summarizing feasibility and potential short-term benefits.
Study overview
- Study title
- Exercise snacking for chronic conditions and cardiometabolic risk: An evidence map and scoping review.
- Study authors
- Ding Yihua, Cui Hui, Li Xiang, Qin Yuxuan, Zhu Yaqin, Yu Ning, Zhang Yanhong
- Population
- People with chronic conditions, cardiometabolic risk factors, or metabolic disorders; evidence was concentrated in populations with metabolic disorders and limited geographical regions.
- Sample size
- 560
- Duration
- Acute studies (3–24 hours), short-term studies (2–4 days), and longer-term interventions (3–12 weeks).
- Outcomes
- Metabolism-related indices, Physical function, Body composition, Neurocognitive function, Quality of life, Feasibility
Intervention
Main findings
The review mapped potential short-term benefits and feasibility-related outcomes of exercise snacking. Evidence was concentrated in acute studies and populations with metabolic disorders, while long-term clinical effectiveness, safety, optimal dosage, and disease-specific recommendations remained uncertain.
What this may mean in practice
Snacksmate's reading of the evidence — not a quotation from the original paper.
Current evidence is insufficient to determine the long-term clinical effectiveness, safety, or best dosage of exercise snacking for chronic conditions and cardiometabolic risk. The review supports further rigorous, longer-term research rather than disease-specific recommendations.
Limitations
The evidence was dominated by acute laboratory studies, concentrated in populations with metabolic disorders and limited geographical regions, and insufficient for determining long-term outcomes, safety, implementation, optimal dosage, or disease-specific recommendations. Appraisal also identified limitations in allocation concealment and blinding.
Original study
What can you take from this?
The notes above are Snacksmate’s reading of this study, not personal advice.